Form 8-K - Current report:
SEC Accession No. 0001144204-19-041837
Filing Date
2019-08-27
Accepted
2019-08-27 16:31:48
Documents
3
Period of Report
2019-08-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv528362_8k.htm 8-K 20561
2 EXHIBIT 99.1 tv528362_ex99-1.htm EX-99.1 515413
3 GRAPHIC tv528362_img01.jpg GRAPHIC 7168
  Complete submission text file 0001144204-19-041837.txt   547313
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 191057704
SIC: 2834 Pharmaceutical Preparations